Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019-2020 Influenza Season.

Mahrukh ImranJoan Puig-BarberaJustin R OrtizLauren FischerDan O'BrienMachaon BonafedeJames A MansiConstantina Boikos

Published in: Open forum infectious diseases (2022)

Adults age ≥65 years vaccinated with aIIV3 had fewer influenza-related medical encounters compared with IIV4e or HD-IIV3 during the 2019-2020 US influenza season.

Keyphrases

randomized controlled trial
systematic review